Siemens Shares Slip Despite Record Performance and Raised Outlook

Siemens posts strong Q1 revenue and record backlog but shares drop 10% as investor caution over the planned Healthineers spin-off overshadows operational strength.

Strong operational results and an upgraded annual forecast from Siemens have failed to impress the market, with investor caution driving the share price lower. The source of this skepticism lies not in the company's thriving core business but in the looming uncertainty surrounding the planned separation of its medical technology subsidiary, Healthineers.

Investor Caution Overshadows Operational Strength

Financially, Siemens is performing exceptionally. For the first quarter of fiscal 2026, revenue climbed to €19.1 billion. The order backlog simultaneously swelled to a new record of €120 billion. This growth is being powered significantly by robust demand for cloud infrastructure and data centers in the United States. In response to these powerful fundamentals, management has raised its profit guidance for the full year.

However, this operational optimism is not reflected in the company's stock performance. Closing yesterday at €229.85, the share price stands approximately ten percent lower than its level one month ago. This decline has also pushed the stock below the closely watched 200-day moving average, which currently sits at €235.53.

Healthineers Spin-Off Plans Create Uncertainty

The primary reason investors are withholding praise for the strong figures is a strategic move by the executive and supervisory boards. They plan to relinquish Siemens' majority stake in Siemens Healthineers. The proposal involves a direct spin-off of roughly 30 percent of Healthineers shares to existing Siemens shareholders. This would cause the parent company to lose its controlling interest, with the remaining stake held as a financial investment in the medium term. With detailed plans on the transaction's structure and timeline not expected until early in the second quarter, many market participants are currently avoiding risk and securing profits.

Counterweights: AI Focus and Share Buybacks

Amid this structural shift, Siemens continues to advance its digital transformation by expanding its software and artificial intelligence strategy. The integration of the software provider Altair, acquired last year, forms the technological foundation for this push. Furthermore, the conglomerate is deepening its partnership with NVIDIA to co-develop an AI operating system tailored for industrial applications.

These operational initiatives are being flanked by an ongoing share repurchase program. Of the €6 billion authorized for buybacks, €4.4 billion has already been utilized. In March alone, the company retired 18 million of its own shares, a move that provides ongoing support for earnings per share.

For now, the operational strength in infrastructure and data centers is being overshadowed by corporate restructuring. New momentum for the equity is likely to depend on the detailed Healthineers transaction plans expected early in Q2. When the next quarterly report is published on May 13, 2026, it will become clear whether the robust fundamental data is sufficient to sustainably lift the share price back above its 200-day average.